Literature DB >> 9797712

Screening by mammography, women with a family history of breast cancer.

F Lalloo, C R Boggis, D G Evans, A Shenton, A G Threlfall, A Howell.   

Abstract

The aim of this study was to describe the experience of screening women under the age of 50 years with a family history of breast cancer. 1259 women attended the Family History Clinic in Manchester for their first and subsequent consultations between 30 September 1992 and 30 April 1997. All women were under the age of 50 years at the initial consultation and had a lifetime risk of breast cancer of 1 in 6 or greater. Seven prevalent, seven incident and two interval cancers were detected. The number of invasive cancers expected to occur if this high risk population had not been screened was 8.45 (in 2722 person years at risk). 12 invasive cancers were detected, giving a ratio of 1.42 (95% confidence interval 0.73-2.48). The overall cancer detection rates in this young, at risk population were similar to those in older women in the National Health Service Breast Screening Programme. The number of cancers detected in the study was greater than expected in this population. As the numbers were small, a national trial needs to be undertaken to confirm these results and to determine the long term effects of screening.

Entities:  

Mesh:

Year:  1998        PMID: 9797712     DOI: 10.1016/s0959-8049(98)00005-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  16 in total

Review 1.  Evidence based case report: Advice about mammography for a young woman with a family history of breast cancer.

Authors:  A Lucassen; E Watson; D Eccles
Journal:  BMJ       Date:  2001-04-28

2.  Evaluation of questionnaire on cancer family history in identifying patients at increased genetic risk in general practice.

Authors:  V Leggatt; J Mackay; J R Yates
Journal:  BMJ       Date:  1999-09-18

3.  Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG).

Authors:  D M Eccles; D G Evans; J Mackay
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

4.  Evaluation of questionnaire on cancer family history in general practice. Principal role of primary care is not to seek out those at increased genetic risk.

Authors:  J Emery
Journal:  BMJ       Date:  2000-01-15

Review 5.  Risk assessment and management of high risk familial breast cancer.

Authors:  D G R Evans; F Lalloo
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

Review 6.  Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?

Authors:  Francesco Sardanelli; Franca Podo
Journal:  Eur Radiol       Date:  2006-09-29       Impact factor: 5.315

7.  An audit of screening for familial breast cancer before 50 years in the South Thames Region - have we got it right?

Authors:  Victoria Murday; R Pears; J Ball; R Eeles; S Hodgson
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

8.  Outcomes of multimodality breast screening for women at increased risk of familial breast cancer.

Authors:  Ian C Bennett; Jennifer Muller; Linda Cockburn; Helen Joshua; Gillian Thorley; Christine Baker; Nili Wood; Jane Brazier; Mark Jones; Nathan Dunn; Michael Gattas
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

Review 9.  The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology.

Authors:  F Lalloo; D G Evans
Journal:  Breast Cancer Res       Date:  1999-10-27       Impact factor: 6.466

10.  Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience.

Authors:  Laura Cortesi; Daniela Turchetti; Isabella Marchi; Antonella Fracca; Barbara Canossi; Battista Rachele; Ruscelli Silvia; Pecchi Anna Rita; Torricelli Pietro; Federico Massimo
Journal:  BMC Cancer       Date:  2006-08-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.